The Discounted Cash Flow (DCF) valuation of Inhibrx Inc (INBX) is (340.87) USD. With the latest stock price at 88.66 USD, the upside of Inhibrx Inc based on DCF is -484.5%.
Based on the latest price of 88.66 USD and our DCF valuation, Inhibrx Inc (INBX) is a sell. selling INBX stocks now will result in a potential gain of 484.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.7% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,258.80) - (204.34) | (340.87) |
| Upside | -1519.8% - -330.5% | -484.5% |